Aarti Drugs Ltd. - Research Center
524348 AARTIDRUGS Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 2,266.91 | 2,497.97 | 2,251.17 | 1,914.89 | 1,634.92 |
| Operating profit | 266.13 | 282.40 | 318.18 | 401.28 | 244.40 |
| Interest | 30.16 | 32.53 | 20.06 | 22.61 | 32.20 |
| Gross profit | 240.15 | 252.10 | 302.89 | 385.09 | 213.26 |
| EPS (Rs) | 15.43 | 16.50 | 21.06 | 27.65 | 58.23 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 4.18 | 2.23 | 4.77 | 6.42 | 1.06 |
| Stock adjustment | 26.77 | -6.72 | -77.94 | -9.08 | -53.94 |
| Raw material | 1,466.57 | 1,702.44 | 1,524.56 | 1,127.79 | 1,078.80 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 80.98 | 74.99 | 69.32 | 69.29 | 60.10 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 426.46 | 444.86 | 417.05 | 325.61 | 305.56 |
| Provisions made | - | - | - | - | - |
| Depreciation | 47.67 | 47.29 | 47.39 | 47.60 | 46.67 |
| Taxation | 50.60 | 52.00 | 60.50 | 80.00 | 39.30 |
| Net profit / loss | 141.88 | 152.81 | 195.00 | 257.71 | 135.67 |
| Extra ordinary item | - | - | - | 0.22 | 8.38 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 91.94 | 92.60 | 92.60 | 93.20 | 23.30 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 11.74 | 11.31 | 14.13 | 20.96 | 14.95 |
| GPM (%) | 10.57 | 10.08 | 13.43 | 20.04 | 13.04 |
| NPM (%) | 6.25 | 6.11 | 8.64 | 13.41 | 8.29 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis